AC
ARMISTICE CAPITAL, LLC
ARMISTICE CAPITAL, LLC · Investor
1Y performance ⓘ
+46%
AUM (13F)
$5.6B
# of Holdings
248
3Y performance ⓘ
+60%
vs S&P 500 ⓘ
−3%
Updated
Mar 31
ARMISTICE CAPITAL, LLC's ARMISTICE CAPITAL, LLC holds 248 U.S.-equity positions worth $5.6B (SEC 13F, Q1 2026). Top positions: State Str Spdr S&p 500 Etf T 24.3%, Ishares Tr 15.4%, Agios Pharmaceuticals, Inc. 3.6%. 13F-replication return is +60% over 3 years (-3 pts vs the S&P 500) — a replicated, non-audited figure.
Holdings
| Stock | % of portfolio | Shares | Value | Latest activity | Avg buy price | Current price | Date |
|---|---|---|---|---|---|---|---|
| SPY State Str Spdr S&p 500 Etf T | 24.3% | 2.1M | $1.4B | ▼ 30% (−900K) | $603.30 | $747.03 (+24%) | 2026-03-31 |
| IWM Ishares Tr | 15.4% | 3.5M | $868M | ▼ 57% (−4.6M) | $227.14 | $291.20 (+28%) | 2026-03-31 |
| AGIO Agios Pharmaceuticals, Inc. | 3.6% | 5.9M | $200M | ▼ 2.0% (−120K) | $28.33 | $30.02 (+6%) | 2026-03-31 |
| CYTK Cytokinetics Inc. | 3.1% | 2.7M | $176M | ▲ 6.9% (+172K) | $58.68 | $77.13 (+31%) | 2026-03-31 |
| PTCT PTC Therapeutics, Inc. | 3.0% | 2.5M | $168M | ▼ 12% (−337K) | $34.83 | $68.01 (+95%) | 2026-03-31 |
| TVTX Travere Therapeutics, Inc. Common Stock | 2.6% | 4.9M | $146M | ▲ 30% (+1.1M) | $23.08 | $55.89 (+142%) | 2026-03-31 |
| MDGL Madrigal Pharmaceuticals, Inc. Common Stock | 2.5% | 265K | $139M | — | $500.04 | $467.32 (−7%) | 2026-03-31 |
| IMVT Immunovant, Inc. Common Stock | 2.4% | 5.5M | $136M | ▼ 16% (−1.0M) | $28.42 | $38.62 (+36%) | 2026-03-31 |
| SUPN Supernus Pharmaceuticals, Inc. | 1.7% | 1.9M | $98M | ▼ 31% (−869K) | $32.56 | $44.63 (+37%) | 2026-03-31 |
| NBIX Neurocrine Biosciences Inc | 1.7% | 724K | $95M | ▼ 12% (−96K) | $129.78 | $166.80 (+29%) | 2026-03-31 |
| FRPT Freshpet, Inc. | 1.1% | 1.1M | $64M | ▼ 16% (−203K) | $66.75 | $59.54 (−11%) | 2026-03-31 |
| INCY Incyte Genomics Inc | 1.1% | 657K | $62M | ▼ 40% (−441K) | $60.09 | $119.52 (+99%) | 2026-03-31 |
| DYN Dyne Therapeutics, Inc. Common Stock | 1.0% | 3.2M | $58M | ▼ 2.3% (−75K) | $13.21 | $25.18 (+91%) | 2026-03-31 |
| AMZN Amazon.Com Inc | 1.0% | 262K | $55M | ▼ 29% (−105K) | $187.37 | $271.58 (+45%) | 2026-03-31 |
| IRWD Ironwood Pharmaceuticals, Inc. - Class A | 0.9% | 15.0M | $53M | ▼ 6.2% (−997K) | $5.37 | $4.23 (−21%) | 2026-03-31 |
| S SentinelOne, Inc. | 0.8% | 3.5M | $46M | ▼ 37% (−2.1M) | $16.45 | $19.06 (+16%) | 2026-03-31 |
| HRMY Harmony Biosciences Holdings, Inc. Common Stock | 0.8% | 1.6M | $45M | ▲ 225% (+1.1M) | $30.91 | $35.24 (+14%) | 2026-03-31 |
| TMO Thermo Fisher Scientific, Inc. | 0.8% | 91K | $45M | ▲ 46% (+29K) | $502.55 | $574.30 (+14%) | 2026-03-31 |
| FIVN FIVE9, INC. | 0.8% | 2.8M | $43M | ▼ 25% (−958K) | $24.01 | $27.51 (+15%) | 2026-03-31 |
| NKTR Nektar Therapeutics | 0.7% | 578K | $42M | ▼ 3.0% (−18K) | $42.39 | $70.67 (+67%) | 2026-03-31 |
| UNH UNITEDHEALTH GROUP INCORPORATED (Delaware) | 0.7% | 148K | $40M | NEW (+148K) | $338.83 | $414.40 (+22%) | 2026-03-31 |
| UBER Uber Technologies, Inc. | 0.7% | 519K | $37M | ▲ 83% (+236K) | $73.34 | $70.36 (−4%) | 2026-03-31 |
| PENN PENN Entertainment, Inc. Common Stock | 0.7% | 2.5M | $37M | ▼ 20% (−618K) | $17.73 | $20.53 (+16%) | 2026-03-31 |
| IMCR Immunocore Hldgs Plc | 0.6% | 1.2M | $36M | ▲ 8.2% (+90K) | $34.98 | $33.81 (−3%) | 2026-03-31 |
| XRAY DENTSPLY SIRONA Inc. | 0.6% | 3.0M | $35M | ▼ 59% (−4.3M) | $13.66 | $13.37 (−2%) | 2026-03-31 |
| RIGL Rigel Pharmaceuticals Inc. (New) | 0.6% | 1.3M | $35M | ▲ 53% (+444K) | $19.35 | $36.81 (+90%) | 2026-03-31 |
| IRON Disc Medicine, Inc. Common Stock | 0.6% | 536K | $34M | ▲ 7.3% (+37K) | $59.02 | $77.00 (+30%) | 2026-03-31 |
| GOOGL Alphabet Inc. Class A Common Stock | 0.6% | 119K | $34M | ▼ 40% (−78K) | $163.01 | $356.13 (+118%) | 2026-03-31 |
| MLYS Mineralys Therapeutics, Inc. Common Stock | 0.6% | 1.2M | $32M | ▲ 74% (+500K) | $29.39 | $25.52 (−13%) | 2026-03-31 |
| HUBS HUBSPOT, INC. | 0.6% | 129K | $31M | ▲ 89% (+61K) | $366.29 | $237.36 (−35%) | 2026-03-31 |
| AXGN Axogen, Inc. Common Stock | 0.6% | 936K | $31M | — | $13.17 | $42.21 (+220%) | 2026-03-31 |
| OFIX Orthofix Medical Inc. Common Stock (DE) | 0.6% | 2.7M | $31M | ▲ 2.0% (+52K) | $15.56 | $11.80 (−24%) | 2026-03-31 |
| KURA Kura Oncology, Inc. | 0.5% | 3.7M | $30M | ▼ 24% (−1.2M) | $10.36 | $9.01 (−13%) | 2026-03-31 |
| AVNS Avanos Medical, Inc. | 0.5% | 2.0M | $28M | ▼ 38% (−1.2M) | $13.23 | — (+6%) | 2026-03-31 |
| REGN Regeneron Pharmaceuticals Inc | 0.5% | 36K | $28M | ▼ 57% (−48K) | $658.19 | $762.63 (+16%) | 2026-03-31 |
| ALGN Align Technology Inc | 0.5% | 158K | $27M | ▲ 108% (+82K) | $164.07 | $169.16 (+3%) | 2026-03-31 |
| MDB MongoDB, Inc. Class A | 0.5% | 107K | $26M | ▲ 118% (+58K) | $226.93 | $337.48 (+49%) | 2026-03-31 |
| BABA Alibaba Group Hldg Ltd | 0.5% | 204K | $26M | ▼ 36% (−115K) | $145.19 | $122.25 (−16%) | 2026-03-31 |
| MDLN Medline Inc. Class A common stock | 0.5% | 565K | $25M | ▲ 874% (+507K) | $44.24 | $39.28 (−11%) | 2026-03-31 |
| DDOG Datadog, Inc. Class A Common Stock | 0.4% | 209K | $25M | ▼ 15% (−36K) | $117.03 | $267.97 (+129%) | 2026-03-31 |
| HUM Humana Inc. | 0.4% | 141K | $24M | ▲ 97% (+70K) | $231.20 | $363.86 (+57%) | 2026-03-31 |
| VSTM Verastem, Inc. | 0.4% | 4.6M | $24M | ▲ 30% (+1.1M) | $5.20 | $5.80 (+12%) | 2026-03-31 |
| ISRG Intuitive Surgical Inc. | 0.4% | 52K | $24M | ▼ 15% (−9K) | $451.77 | $353.33 (−22%) | 2026-03-31 |
| GRFS Grifols S A | 0.4% | 3.0M | $24M | ▲ 7.9% (+220K) | $7.52 | $7.87 (+5%) | 2026-03-31 |
| SLDB Solid Biosciences Inc. Common Stock | 0.4% | 3.2M | $23M | ▲ 23% (+588K) | $5.92 | $8.06 (+36%) | 2026-03-31 |
| GTLB GitLab Inc. Class A Common Stock | 0.4% | 1.0M | $22M | ▲ 20% (+170K) | $37.68 | $34.51 (−8%) | 2026-03-31 |
| AUTL Autolus Therapeutics Ltd | 0.4% | 15.8M | $22M | ▼ 9.7% (−1.7M) | $2.30 | $1.49 (−35%) | 2026-03-31 |
| ANGO AngioDynamics, Inc. | 0.4% | 1.9M | $21M | ▲ 9.9% (+169K) | $9.21 | $14.79 (+61%) | 2026-03-31 |
| ARVN Arvinas, Inc | 0.4% | 2.0M | $21M | ▲ 9.9% (+178K) | $9.39 | $8.03 (−15%) | 2026-03-31 |
| TSM Taiwan Semiconductor Manufac | 0.4% | 61K | $21M | ▲ 23% (+11K) | $197.79 | $404.25 (+104%) | 2026-03-31 |
Showing top 50 of 248 holdings by value.
FAQ ▾
What are ARMISTICE CAPITAL, LLC's largest holdings?
As of the latest 13F: State Str Spdr S&p 500 Etf T 24.3%, Ishares Tr 15.4%, Agios Pharmaceuticals, Inc. 3.6%, Cytokinetics Inc. 3.1%, PTC Therapeutics, Inc. 3.0%.
How big is ARMISTICE CAPITAL, LLC's 13F portfolio?
$5.6B across 248 disclosed U.S.-equity positions.
What is ARMISTICE CAPITAL, LLC's 3-year performance?
+60% (13F-replication, price return), -3 pts vs the S&P 500. Not an audited fund return.
Where does this data come from?
U.S. SEC Form 13F-HR institutional holdings filings.
Sourced from SEC Form 13F-HR filings · Not investment advice ▾
Data as of 2026-03-31 · Methodology
13F-replication (price return, filing-date based) — not an audited fund return.
Published by WealthFile · Not investment advice.
Latest activity = change vs. the prior 13F. Avg buy price = est. entry over the trailing 3 years (gain = vs. latest price). Returns are 13F-replication, not audited fund returns. Sourced from SEC 13F filings.